B2Gold and Vertex Pharmaceuticals stand out as strong buys, driven by robust fundamentals, sector leadership, and clear growth catalysts for 2025 and beyond. Caution is urged on popular income-focused …
Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More
view original post